thiazoles has been researched along with srt3025 in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arsiwala, T; Auwerx, J; Ellis, JL; Gomes, AP; Hottiger, MO; Lohmann, C; Lüscher, TF; Lutz, TA; Matter, CM; Miranda, MX; Schoonjans, K; Sinclair, DA; Staels, B; Stein, S; Suri, V; Tailleux, A; van Tits, LJ; Winnik, S | 1 |
| Advani, SL; Cummins, CL; Gilbert, RE; Kepecs, DM; Schroer, SA; Thai, K; Woo, M; Zhang, Y | 1 |
| Deater, M; Grompe, M; Marquez-Loza, L; Pelz, C; Schubert, K; Sinclair, DA; Zhang, QS | 1 |
| Artsi, H; Ben-Shalom, G; Cohen-Kfir, E; Dresner-Pollak, R; El-Haj, M; Feinstein, B; Gurt, I; Hamdani, G | 1 |
| Billadeau, DD; Chini, CC; Chini, EN; Escande, C; Espindola-Netto, JM; Guerrico, AM; Mondal, G; Nin, V; Sola-Penna, M; Zhang, JS | 1 |
| Chahin, A; Chahin, AB; Ellis, JL; Freudenberg, JM; Kessimian, N; Li, Y; Opal, SM; Palardy, JE; Parejo, N; Suri, V; Vlasuk, GP; Yamamoto, M | 1 |
| Connelly, KA; Gilbert, RE; Kapus, A; Kepecs, D; Thai, K; Wu, X; Zhang, Y | 1 |
| Gilbert, RE; Jin, T; Thai, K; Woo, M; Zhang, Y | 1 |
| Lin, X; Liu, C; Shao, Z; Wang, H; Wang, T | 1 |
| Connelly, KA; Desjardins, JF; Gilbert, RE; Kabir, G; Thai, K; Veitch, MR; Zhang, Y | 1 |
1 trial(s) available for thiazoles and srt3025
| Article | Year |
|---|---|
Sirt1 in the Regulation of Interferon Gamma in Severe Aplastic Anemia.
Topics: Adult; Aged; Anemia, Aplastic; Anilides; Animals; CD8-Positive T-Lymphocytes; Enzyme Activators; Female; Humans; Interferon-gamma; Male; Mice; Middle Aged; Severity of Illness Index; Sirtuin 1; Thiazoles | 2019 |
9 other study(ies) available for thiazoles and srt3025
| Article | Year |
|---|---|
The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.
Topics: Anilides; Animals; Anticholesteremic Agents; Apolipoproteins E; Arteriosclerosis; Cells, Cultured; Cholesterol, LDL; Enzyme Inhibitors; Hepatocytes; In Vitro Techniques; Male; Mice, Inbred C57BL; Proprotein Convertase 9; Proprotein Convertases; Receptors, LDL; RNA, Messenger; Serine Endopeptidases; Sirtuin 1; Thiazoles | 2015 |
SIRT1 activation ameliorates hyperglycaemia by inducing a torpor-like state in an obese mouse model of type 2 diabetes.
Topics: Angiopoietin-Like Protein 8; Angiopoietin-like Proteins; Anilides; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Enzyme Activators; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Male; Mice, Mutant Strains; Obesity; Peptide Hormones; Signal Transduction; Sirtuin 1; Thiazoles; Time Factors; Torpor | 2015 |
The Sirt1 activator SRT3025 expands hematopoietic stem and progenitor cells and improves hematopoiesis in Fanconi anemia mice.
Topics: Acetaldehyde; Anilides; Animals; Blood Cell Count; Cell Proliferation; Diet; Ethanol; Fanconi Anemia; Gene Deletion; Gene Expression Profiling; Hematopoiesis; Hematopoietic Stem Cells; Mice, Transgenic; Sequence Analysis, RNA; Sirtuin 1; Thiazoles; Transcriptome | 2015 |
The Sirt1 Activators SRT2183 and SRT3025 Inhibit RANKL-Induced Osteoclastogenesis in Bone Marrow-Derived Macrophages and Down-Regulate Sirt3 in Sirt1 Null Cells.
Topics: Anilides; Animals; Bone Marrow Cells; Cell Line; Down-Regulation; Female; Heterocyclic Compounds, 4 or More Rings; Macrophages; Mice; Osteoclasts; RANK Ligand; Sirtuin 1; Sirtuin 3; Thiazoles | 2015 |
SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway.
Topics: Anilides; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Female; Gemcitabine; Heterocyclic Compounds, 4 or More Rings; Humans; Lysosomes; Mice; Mice, Nude; Paclitaxel; Pancreatic Neoplasms; Sirtuin 1; Thiazoles | 2016 |
PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS.
Topics: Anilides; Animals; Disease Models, Animal; Enzyme Activation; Female; Immunity, Innate; Mice; Sepsis; Sirtuin 1; Streptococcal Infections; Streptococcus pneumoniae; Thiazoles; Transcription, Genetic | 2016 |
Sirtuin 1 Activation Reduces Transforming Growth Factor-β1-Induced Fibrogenesis and Affords Organ Protection in a Model of Progressive, Experimental Kidney and Associated Cardiac Disease.
Topics: Acetylation; Anilides; Animals; Biopsy; Blood Pressure; Collagen; Disease Models, Animal; Disease Progression; Feeding Behavior; Fibrosis; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Heart Diseases; Heart Function Tests; HEK293 Cells; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Proline; Rats, Inbred F344; Renal Insufficiency, Chronic; RNA, Messenger; Sirtuin 1; Smad3 Protein; Thiazoles; Transforming Growth Factor beta1 | 2017 |
SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice.
Topics: Anilides; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Hyperglycemia; Hyperplasia; Insulin; Male; Mice; Sirtuin 1; Thiazoles | 2018 |
Late intervention in the remnant kidney model attenuates proteinuria but not glomerular filtration rate decline.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anilides; Animals; Disease Models, Animal; Disease Progression; Enalapril; Glomerular Filtration Rate; Hypertension; Kidney; Nephrectomy; Postoperative Complications; Proteinuria; Rats; Renal Insufficiency, Chronic; Sirtuin 1; Thiazoles | 2021 |